Overview

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Status:
Enrolling by invitation

Trial end date:
2025-05-26

Target enrollment:

Participant gender:

Summary

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

Phase:

Phase 3

Details

Lead Sponsor:

AbbVie

Treatments:

Venetoclax